Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Go back to Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Bruker (BRKR) PT Raised to $32 at UBS

February 12, 2019 9:08 AM EST

UBS analyst Dan Brennan raised the price target on Bruker (NASDAQ: BRKR) to $32.00 (from $30.00) while maintaining a Sell rating.

... More

Bruker (BRKR) PT Raised to $37 at Cowen

February 12, 2019 7:34 AM EST

Cowen analyst Doug Schenkel raised the price target on Bruker (NASDAQ: BRKR) to $37.00 (from $32.00) while maintaining a Market Perform rating.

... More

Bruker (BRKR) Reports In-Line Q4 EPS, Offers FY Guidance

February 11, 2019 4:07 PM EST

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $553.6 million versus the consensus estimate of $544.6 million.

GUIDANCE:

Bruker sees FY2019 EPS of $1.54-$1.58, versus the consensus of $1.55.

For FY 2019, the... More